These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 1581439

  • 21. Effects of scopolamine parenteral administration on the electroretinogram, visual evoked potentials, and quantitative electroencephalogram of healthy volunteers.
    Sannita WG, Fioretto M, Maggi L, Rosadini G.
    Doc Ophthalmol; 1987 Dec; 67(4):379-88. PubMed ID: 3454320
    [Abstract] [Full Text] [Related]

  • 22. Cholinergic and serotonergic effects on the P3 potential and recent memory.
    Meador KJ, Loring DW, Davis HC, Sethi KD, Patel BR, Adams RJ, Hammond EJ.
    J Clin Exp Neuropsychol; 1989 Mar; 11(2):252-60. PubMed ID: 2925834
    [Abstract] [Full Text] [Related]

  • 23. Long-term suppression in mice of the development of complementary memory storage sites: effect of a muscarinic antagonist.
    Flexner LB, Flexner JB, Church AC.
    Pharmacol Biochem Behav; 1991 Jul; 39(3):689-94. PubMed ID: 1784597
    [Abstract] [Full Text] [Related]

  • 24. Scopolamine disruption of septo-hippocampal activity and classical conditioning.
    Salvatierra AT, Berry SD.
    Behav Neurosci; 1989 Aug; 103(4):715-21. PubMed ID: 2765176
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Scopolamine blocks olfaction-induced fast waves but not olfactory evoked potentials in the dentate gyrus.
    Heale VR, Vanderwolf CH.
    Behav Brain Res; 1995 Apr; 68(1):57-64. PubMed ID: 7619306
    [Abstract] [Full Text] [Related]

  • 30. Scopolamine effects on memory, language, visuospatial praxis and psychomotor speed.
    Flicker C, Serby M, Ferris SH.
    Psychopharmacology (Berl); 1990 Apr; 100(2):243-50. PubMed ID: 2305013
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Antagonism of physostigmine induced lethality by a combination of scopolamine and methscopolamine.
    Janowsky DS, Berkowitz A, Turken A, Risch SC.
    Acta Pharmacol Toxicol (Copenh); 1985 Feb; 56(2):154-7. PubMed ID: 3993383
    [Abstract] [Full Text] [Related]

  • 33. Aging and cholinergic modulation of the transient magnetic 40-Hz auditory response.
    Ahveninen J, Jääskeläinen IP, Kaakkola S, Tiitinen H, Pekkonen E.
    Neuroimage; 2002 Jan; 15(1):153-8. PubMed ID: 11771983
    [Abstract] [Full Text] [Related]

  • 34. Effects of scopolamine on MEG spectral power and coherence in elderly subjects.
    Osipova D, Ahveninen J, Kaakkola S, Jääskeläinen IP, Huttunen J, Pekkonen E.
    Clin Neurophysiol; 2003 Oct; 114(10):1902-7. PubMed ID: 14499752
    [Abstract] [Full Text] [Related]

  • 35. The effects of aniracetam on primate behavior and EEG.
    Schwam E, Keim K, Cumin R, Gamzu E, Sepinwall J.
    Ann N Y Acad Sci; 1985 Oct; 444():482-4. PubMed ID: 3860103
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Effects of scopolamine and methscopolamine on acquisition and retention of rat one-way shuttle box behavior and total brain acetylcholine.
    Domino KB, Domino EF.
    Arch Int Pharmacodyn Ther; 1976 Dec; 224(2):248-57. PubMed ID: 1015922
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.